Vaccine News [Research]
Vaccine News: Research [September 2-9]
Research Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of Alberta 09 Sep, 2024 RSV vaccination in older adults with health conditions is cost-effective, modeling study finds 09 Sep, 2024 Long COVID significantly affects Read more…